Waypoint Capital taps ex-Sanofi CEO to lead healthcare fund

Waypoint Capital has named Christopher A. Viehbacher as managing partner of its healthcare-focused Gurnet Point Capital fund. His appointment becomes effective July 1. Previously, Viehbacher was CEO of Sanofi and chairman of Genzyme.

23 June 2015•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles